As the world’s leading Pharmaceutical giants race to defeat the deadly Coronavirus, Johnson & Johnson announced on Monday it plans to initiate human clinical trials of its Covid-19 vaccine candidate by September.
The company said it anticipates the first batches of the vaccine could be avai
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
